SCHEMBL5776720

SCHEMBL5776720

O=Cc1c[nH]nc1Cc1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.48
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.38
DAO P14920 1/20 0.37
P2RX7 Q99572 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
MPO P05164 1/20 0.35
IDO1 P14902 2/20 0.35
HCAR3 P49019 1/20 0.35
ERN1 O75460 1/20 0.34
AKR1B1 P15121 1/20 0.34
TAAR1 Q96RJ0 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15093846 0.82 AR (0.48) ARALDH1A1HTTSMN1; SMN2KDM4E
SCHEMBL5780286 0.79 PARP1 (0.44) ARALDH1A1HTTSMN1; SMN2KDM4E
SCHEMBL17619356 0.76 AR (0.48) ARALDH1A1KDM4EDAOP2RX7
SCHEMBL15622305 0.75 AR (0.47) ARALDH1A1KDM4EMEN1KMT2A
SCHEMBL17619354 0.74 AR (0.49) ARALDH1A1SMN1; SMN2KDM4EMEN1
SCHEMBL16781994 0.73 ALDH1A1 (0.47) ARALDH1A1HTTSMN1; SMN2DAO
SCHEMBL20976756 0.71 AR (0.43) ARALDH1A1KDM4EDAOP2RX7
SCHEMBL20578752 0.71 AR (0.52) ARALDH1A1HTTKDM4EDAO
SCHEMBL4535793 0.70 AR (0.48) ARALDH1A1HTTSMN1; SMN2KDM4E
SCHEMBL5779565 0.70 L3MBTL1 (0.48) ARALDH1A1SMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897953-B1 SGC STIMULATORS IRONWOOD PHARMACEUTICALS INC (US) 2019-05-08 EP disclosed
EP-1678181-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-07-12 EP disclosed
WO-2005042534-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2005-05-12 WO disclosed